Bio Techne Stock Forward View - Polynomial Regression
| TECH Stock | USD 57.92 0.05 0.09% |
Bio Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Bio Techne's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 26th of February 2026, the relative strength index (RSI) of Bio Techne's share price is approaching 43. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bio Techne, making its price go up or down. Momentum 43
Sell Extended
Oversold | Overbought |
Using Bio Techne hype-based prediction, you can estimate the value of Bio Techne Corp from the perspective of Bio Techne response to recently generated media hype and the effects of current headlines on its competitors.
The Polynomial Regression forecasted value of Bio Techne Corp on the next trading day is expected to be 50.35 with a mean absolute deviation of 1.85 and the sum of the absolute errors of 112.57. Bio Techne after-hype prediction price | USD 57.59 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Bio Techne to cross-verify your projections. Bio Techne Additional Predictive Modules
Most predictive techniques to examine Bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bio using various technical indicators. When you analyze Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bio Techne Polynomial Regression Price Forecast For the 27th of February
Given 90 days horizon, the Polynomial Regression forecasted value of Bio Techne Corp on the next trading day is expected to be 50.35 with a mean absolute deviation of 1.85, mean absolute percentage error of 4.87, and the sum of the absolute errors of 112.57.Please note that although there have been many attempts to predict Bio Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bio Techne's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bio Techne Stock Forecast Pattern
| Backtest Bio Techne | Bio Techne Price Prediction | Research Analysis |
Bio Techne Forecasted Value
In the context of forecasting Bio Techne's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bio Techne's downside and upside margins for the forecasting period are 47.97 and 52.74, respectively. We have considered Bio Techne's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Bio Techne stock data series using in forecasting. Note that when a statistical model is used to represent Bio Techne stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 119.6933 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.8454 |
| MAPE | Mean absolute percentage error | 0.0296 |
| SAE | Sum of the absolute errors | 112.5713 |
Predictive Modules for Bio Techne
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bio Techne Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Techne After-Hype Price Density Analysis
As far as predicting the price of Bio Techne at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bio Techne or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bio Techne, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bio Techne Estimiated After-Hype Price Volatility
In the context of predicting Bio Techne's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bio Techne's historical news coverage. Bio Techne's after-hype downside and upside margins for the prediction period are 55.21 and 59.97, respectively. We have considered Bio Techne's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bio Techne is very steady at this time. Analysis and calculation of next after-hype price of Bio Techne Corp is based on 3 months time horizon.
Bio Techne Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Bio Techne is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bio Techne backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bio Techne, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 2.38 | 0.00 | 0.00 | 0 Events / Month | 3 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
57.92 | 57.59 | 0.57 |
|
Bio Techne Hype Timeline
Bio Techne Corp is at this time traded for 57.92. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bio is forecasted to decline in value after the next headline, with the price expected to drop to 57.59. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -0.57%, whereas the daily expected return is at this time at -0.15%. The volatility of related hype on Bio Techne is about 59500.0%, with the expected price after the next announcement by competition of 57.92. About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.83. Bio Techne Corp last dividend was issued on the 13th of February 2026. The entity had 4:1 split on the 30th of November 2022. Given the investment horizon of 90 days the next forecasted press release will be within a week. Check out Historical Fundamental Analysis of Bio Techne to cross-verify your projections.Bio Techne Related Hype Analysis
Having access to credible news sources related to Bio Techne's direct competition is more important than ever and may enhance your ability to predict Bio Techne's future price movements. Getting to know how Bio Techne's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bio Techne may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRNA | Moderna | 0.00 | 0 per month | 3.05 | 0.23 | 9.21 | (5.95) | 23.11 | |
| EXEL | Exelixis | (0.52) | 9 per month | 1.68 | (0.01) | 3.61 | (2.93) | 10.16 | |
| BMRN | Biomarin Pharmaceutical | 0.00 | 0 per month | 1.38 | 0.02 | 3.14 | (2.23) | 22.06 | |
| MDGL | Madrigal Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.20) | 3.41 | (3.53) | 19.67 | |
| RNA | Avidity Biosciences | 0.06 | 9 per month | 0.00 | (0.38) | 0.35 | (0.29) | 1.42 | |
| CAI | Caris Life Sciences | 0.74 | 10 per month | 0.00 | (0.15) | 3.96 | (6.33) | 17.67 | |
| JAZZ | Jazz Pharmaceuticals PLC | 0.00 | 0 per month | 1.99 | 0.01 | 1.70 | (3.95) | 7.24 | |
| RVMD | Revolution Medicines | (0.01) | 10 per month | 2.94 | 0.12 | 4.46 | (2.52) | 45.50 | |
| QGEN | Qiagen NV | 0.00 | 0 per month | 1.21 | 0.02 | 2.53 | (2.52) | 19.84 | |
| CORT | Corcept Therapeutics Incorporated | (0.31) | 8 per month | 0.00 | (0.11) | 6.44 | (10.63) | 54.02 |
Other Forecasting Options for Bio Techne
For every potential investor in Bio, whether a beginner or expert, Bio Techne's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bio. Basic forecasting techniques help filter out the noise by identifying Bio Techne's price trends.Bio Techne Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Techne stock to make a market-neutral strategy. Peer analysis of Bio Techne could also be used in its relative valuation, which is a method of valuing Bio Techne by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bio Techne Market Strength Events
Market strength indicators help investors to evaluate how Bio Techne stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Techne shares will generate the highest return on investment. By undertsting and applying Bio Techne stock market strength indicators, traders can identify Bio Techne Corp entry and exit signals to maximize returns.
Bio Techne Risk Indicators
The analysis of Bio Techne's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bio Techne's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.8 | |||
| Standard Deviation | 2.38 | |||
| Variance | 5.67 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Bio Techne
The number of cover stories for Bio Techne depends on current market conditions and Bio Techne's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bio Techne is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bio Techne's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bio Techne Short Properties
Bio Techne's future price predictability will typically decrease when Bio Techne's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bio Techne Corp often depends not only on the future outlook of the potential Bio Techne's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Techne's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 159.7 M | |
| Cash And Short Term Investments | 162.2 M |
Check out Historical Fundamental Analysis of Bio Techne to cross-verify your projections. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is there potential for Life Sciences Tools & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Bio Techne Corp requires distinguishing between market price and book value, where the latter reflects Bio's accounting equity. The concept of intrinsic value - what Bio Techne's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Bio Techne's price substantially above or below its fundamental value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Bio Techne's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.